Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections

Clinical Transplantation

Volumn 26, Issue 3, 2012, Pages

  Carbone, J ^a   Sarmiento, E ^a   Del Pozo, N ^a   Rodriguez Molina, J J ^a   Navarro, J ^a   Fernandez Yanez J ^a   Palomo, J ^a   Villa, A ^a   Munoz P ^a   Fernandez Cruz, E ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Heart transplantation; Hypogammaglobulinemia; Immunosuppression; Infection; Intravenous immunoglobulin; Monitoring

Indexed keywords

C REACTIVE PROTEIN; HEPATITIS B ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; TETANUS TOXOID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOTHERAPY; INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT;

AGAMMAGLOBULINEMIA; ANTI-INFECTIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFECTION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84862260953     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01653.x     Document Type: Article

References (11)

1. Corales R, Chua J, Mawhorter S et al. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transpl Infect Dis 2000: 2: 133.
2. Yamani MH, Avery RK, Mawhorter SD et al. Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 2001: 20: 425.
3. Sarmiento E, Rodríguez-Molina J, Muñoz P et al. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Transplant Proc 2005: 37: 4046.
4. Sarmiento E, Rodriguez-Molina JJ, Fernandez-Yanez J et al. IgG monitoring to identify the risk for development of infection in heart transplant recipients. Transpl Infect Dis 2006: 8: 49.
5. Carbone J. Adverse reactions and pathogen safety of intravenous immunoglobulin. Current Drug Safety 2007: 2: 9.
6. Carbone J, Sarmiento E, Palomo J et al. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc 2007: 39: 2385.
7. Yamani MH, Avery R, Mawhorter S et al. Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transpl Infect Dis 2001: 3(Suppl 2): 40.
8. Yamani MH, Avery R, Mawhorter SD et al. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study. J Heart Lung Transplant 2005: 24: 1766.
9. Sarmiento E, Fernandez-Yanez J, Munoz P et al. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol 2005: 5: 97.
10. Muñoz P, Giannella M, Alcalá L et al. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer? J Heart Lung Transplant 2007: 26: 907.
11. Daily J, Werner B, Soiffer R, Fingeroth J. IGIV: a potential role for hepatitis B prophylaxis in the bone marrow peritransplant period. Bone Marrow Transplant 1998: 21: 739.